Companies by Name: C

Page: 4 of 15
Displaying 151-200 of 701 results Download this list
▼ Name ▼ Symbol ▼ Market Cap ▼ ADR TSO ▼ Country ▼ IPO Year ▼ Subsector
CBO (Listing Market - NYSE - Networks A/E) n/a n/a n/a n/a
CBOE Holdings, Inc. $5.42B United States 2010 Investment Bankers/Brokers/Service
CBRE Clarion Global Real Estate Income Fund $1.04B United States 2004 n/a
CBRE Group, Inc. $11.64B United States 2004 Real Estate
CBS Corporation $29.01B n/a n/a Broadcasting
CBS Corporation n/a n/a n/a n/a
CBX (Listing Market NYSE Networks AE n/a n/a n/a n/a
CCA Industries, Inc. $23.96M United States n/a Package Goods/Cosmetics
CDI Corporation $341.38M United States n/a Professional Services
CDK Global, Inc. $6.63B United States n/a Business Services
CDW Corporation $6.19B United States 2013 Catalog/Specialty Distribution
CECO Environmental Corp. $407.12M United States n/a Pollution Control Equipment
Cedar Fair, L.P. $2.66B United States 1987 Services-Misc. Amusement & Recreation
Cedar Realty Trust, Inc. $569.54M United States n/a Real Estate Investment Trusts
Cedar Realty Trust, Inc. n/a United States n/a n/a
Celadon Group, Inc. $543.43M United States n/a Trucking Freight/Courier Services
Celanese Corporation $9.29B n/a 2005 Major Chemicals
Celator Pharmaceuticals Inc. $58.94M United States n/a Major Pharmaceuticals
Celestica, Inc. $1.84B Canada 1998 Electrical Products
Celgene Corporation $90.53B United States 1987 Major Pharmaceuticals
Celgene Corporation n/a United States n/a Major Pharmaceuticals
Celladon Corporation $445.58M n/a 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Cellcom Israel, Ltd. $932.84M n/a 2007 Telecommunications Equipment
Celldex Therapeutics, Inc. $1.63B United States n/a Biotechnology: In Vitro & In Vivo Diagnostic Substances
Cellectar Biosciences, Inc. $23.97M United States n/a Major Pharmaceuticals
Cellectar Biosciences, Inc. n/a United States n/a Major Pharmaceuticals
Cellular Biomedicine Group, Inc. $129.3M n/a n/a Finance: Consumer Services
Cellular Dynamics International, Inc. $99.15M United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Cel-Sci Corporation n/a n/a n/a n/a
Cel-Sci Corporation $57.55M United States n/a Biotechnology: Biological Products (No Diagnostic Substances)
Celsion Corporation $46.55M United States n/a Major Pharmaceuticals
Celsus Therapeutics Plc $20.36M United States n/a Major Pharmaceuticals
Cementos Pacasmayo S.A.A. $1.03B n/a 2012 Building Materials
Cemex S.A.B. de C.V. $12.13B Mexico n/a Building Materials
Cempra, Inc. $774.45M United States 2012 Major Pharmaceuticals
Cencosud S.A. $7.04B Chile n/a Department/Specialty Retail Stores
Cenovus Energy Inc $15.62B n/a n/a Oil & Gas Production
Centene Corporation $6.22B United States n/a Medical Specialities
Center Coast MLP & Infrastructure Fund $269.57M n/a 2013 n/a
CenterPoint Energy, Inc. $10.29B United States n/a Electric Utilities: Central
CenterState Banks, Inc. $535.37M United States n/a Major Banks
Centrais Electricas Brasileiras SA n/a n/a n/a n/a
Centrais Electricas Brasileiras SA $2.96B Brazil n/a Electric Utilities: Central
Central Europe, Russia and Turkey Fund, Inc. (The) $220.92M United States n/a n/a
Central European Media Enterprises Ltd. $415.48M Bermuda 1994 Broadcasting
Central Federal Corporation $20.57M United States n/a Savings Institutions
Central Fund of Canada Limited $2.94B Canada n/a n/a
Central Garden & Pet Company $451.63M United States 1993 Consumer Specialties
Central Garden & Pet Company $483.22M United States n/a Consumer Specialties
Central Gold Trust $780.45M Canada n/a n/a
*IPO year information is not available for stocks prior to 1970.